Increased bactericidal/permeability increasing protein in patients with cirrhosis

Liver International

Volumn 30, Issue 1, 2010, Pages 94-101

  Guerra Ruiz, Armando ^a   Casafont, Fernando ^a   Cobo, Marta ^a   Terán, Alvaro ^a   de la Peña, Joaquín ^a   Estebanez, Angel ^a   Pons Romero, Fernando ^a,b  

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^b UNIVERSITY OF CANTABRIA   (Spain)

Author keywords

BPI; endotoxaemia; LBP; Liver disease; LPS binding proteins; TNF

Indexed keywords

BACTERICIDAL PERMEABILITY INCREASING PROTEIN; CD14 ANTIGEN; LIPOPOLYSACCHARIDE BINDING PROTEIN; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE SEVERITY; FEMALE; HUMAN; LEUKOCYTE; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MONOCYTE; NEUTROPHIL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM;

ACUTE-PHASE PROTEINS; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD14; ANTIMICROBIAL CATIONIC PEPTIDES; BLOOD PROTEINS; CARRIER PROTEINS; CELLS, CULTURED; FEMALE; GENE EXPRESSION; HUMANS; LEUKOCYTES, MONONUCLEAR; LIPOPOLYSACCHARIDES; LIVER CIRRHOSIS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; NEUTROPHILS; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 73349102819     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2009.02121.x     Document Type: Article

References (40)

1. Sanchez E, Martin L, Aguero J, Romero F.P. Influence of malnutrition on the prevalence of bacterial translocation and spontaneous bacterial peritonitis in experimental cirrhosis in rats. Hepatology 1997; 25: 1334-7.
2. Bauer TM, Schwacha H, Steinbruckner B, et al. Small intestinal bacterial overgrowth in human cirrhosis is associated with systemic endotoxemia. Am J Gastroenterol 2002; 97: 2364-70.
3. Laleman W, Landeghem L, Wilmer A, Fevery J, Nevens F. Portal hypertension: from pathophysiology to clinical practice. Liver Int 2005; 25: 1079-90.
4. Calvano SE, Thompson WA, Marra MN, et al. Changes in polymorphonuclear leukocyte surface and plasma bactericidal/ permeability-increasing protein and plasma lipopolysaccharide binding protein during endotoxemia or sepsis. Arch Surg 1994; 129: 220-6.
5. Fijen JW, Kobold AC, de Boer P, et al. Leukocyte activation and cytokine production during experimental human endotoxemia. Eur J Intern Med 2000; 11: 89-95.
6. Triantafilou M, Triantafilou K. The dynamics of LPS recognition: complex orchestration of multiple receptors. J Endotoxin Res 2005; 11: 5-11.
7. Kitchens RL, Thompson P.A. Modulatory effects of sCD14 and LBP on LPS-host cell interactions. J Endotoxin Res 2005; 11: 225-9.
8. Marra MN, Wilde CG, Griffith JE, Snable JL, Scott R.W. Bactericidal/permeability-increasing protein has endotoxin-neutralizing activity. J Immunol 1990; 144: 662-6.
9. Elsbach P,Weiss J. The bactericidal/permeability-increasing protein (BPI), a potent element in host-defense against gram-negative bacteria and lipopolysaccharide. Immunobiology 1993; 187: 417-29.
10. Marra MN, Wilde CG, Collins MS, et al. The role of bactericidal/permeability-increasing protein as a natural inhibitor of bacterial endotoxin. J Immunol 1992; 148: 532-7.
11. van Kessel KP, Weersink AJ, Van der Tol ME, Verhoef J. Stimulated human neutrophils release intact BPI without a concomitant change in expression on the cell surface. Prog Clin Biol Res 1995; 392: 305-15.
12. Weiss J. Bactericidal/permeability-increasing protein (BPI) and lipopolysaccharide-binding protein (LBP): structure, function and regulation in host defence against gram-negative bacteria. Biochem Soc Trans 2003; 31(Part 4): 785-90.
13. Schafer C, Parlesak A, Schutt C, Bode JC, Bode C. Concentrations of lipopolysaccharide-binding protein, bactericidal/ permeability-increasing protein, soluble CD14 and plasma lipids in relation to endotoxaemia in patients with alcoholic liver disease. Alcohol Alcohol 2002; 37: 81-6.
14. Chan CC, Hwang SJ, Lee FY, et al. Prognostic value of plasma endotoxin levels in patients with cirrhosis. Scand J Gastroenterol 1997; 32: 942-6.
15. Albillos A, de la HA, Gonzalez M, et al. Increased lipopolysaccharide binding protein in cirrhotic patients with marked immune and hemodynamic derangement. Hepatology 2003; 37: 208-17.
16. Hurley J.C. Endotoxemia: methods of detection and clinical correlates. Clin Microbiol Rev 1995; 8: 268-92.
17. Stadlbauer V, Davies NA, Wright G, Jalan R. Endotoxin measures in patients' sample: how valid are the results? J Hepatol 2007; 47: 726-7.
18. Novitsky T.J. Limitations of the Limulus amebocyte lysate test in demonstrating circulating lipopolysaccharides. Ann NY Acad Sci 1998; 851: 416-21.
19. Munford R.S. Detoxifying endotoxin: time, place and person. J Endotoxin Res 2005; 11: 69-84.
20. Zweigner J, Schumann RR, Weber J.R. The role of lipopolysaccharide-binding protein in modulating the innate immune response. Microbes Infect 2006; 8: 946-52.
21. Lequier LL, Nikaidoh H, Leonard SR, et al. Preoperative and postoperative endotoxemia in children with congenital heart disease. Chest 2000; 117: 1706-12.
22. Hiki N, Berger D, Mimura Y, et al. Release of endotoxinbinding proteins during major elective surgery: role of soluble CD14 in phagocytic activation.World J Surg 2000; 24: 499-506.
23. Wiezer MJ, Meijer C, Sietses C, et al. Bactericidal/permeability-increasing protein preserves leukocyte functions after major liver resection. Ann Surg 2000; 232: 208-15.
24. Schumann RR, Lamping N, Kirschning C, et al. Lipopolysaccharide binding protein: its role and therapeutical potential in inflammation and sepsis. Biochem Soc Trans 1994; 22: 80-2.
25. Genesca J, Marti R, Rojo F, et al. Increased tumour necrosis factor alpha production in mesenteric lymph nodes of cirrhotic patients with ascites. Gut 2003; 52: 1054-9.
26. Wiest R, Das S, Cadelina G, et al. Bacterial translocation in cirrhotic rats stimulates eNOS-derived NO production and impairs mesenteric vascular contractility. J Clin Invest 1999; 104: 1223-33.
27. Le Roy D, Di Padova F, Adachi Y, et al. Critical role of lipopolysaccharide-binding protein and CD14 in immune responses against gram-negative bacteria. J Immunol 2001; 167: 2759-65.
28. Schumann RR, Latz E. Lipopolysaccharide-binding protein. Chem Immunol 2000; 74: 42-60.
29. Bas S, Gauthier BR, Spenato U, Stingelin S, Gabay C. CD14 is an acute-phase protein. J Immunol 2004; 172: 4470-9.
30. Tobias PS, Ulevitch R.J. Lipopolysaccharide binding protein and CD14 in LPS dependent macrophage activation. Immunobiology 1993; 187: 227-32.
31. Ruiz AG, Casafont F, Crespo J, et al. Lipopolysaccharidebinding protein plasma levels and liver TNF-alpha gene expression in obese patients: evidence for the potential role of endotoxin in the pathogenesis of non-alcoholic steatohepatitis. Obes Surg 2007; 17: 1374-80.
32. Kaser A, Ludwiczek O, Waldenberger P, et al. Endotoxin and its binding proteins in chronic liver disease: the effect of transjugular intrahepatic portosystemic shunting. Liver 2002; 22: 380-7.
33. Elsbach P. The bactericidal/permeability-increasing protein (BPI) in antibacterial host defense. J Leukoc Biol 1998; 64: 14-8.
34. Feliu E, Gougerot MA, Hakim J, et al. Blood polymorphonuclear dysfunction in patients with alcoholic cirrhosis. Eur J Clin Invest 1977; 7: 571-7.
35. Fiuza C, Salcedo M, Clemente G, Tellado J.M. In vivo neutrophil dysfunction in cirrhotic patients with advanced liver disease. J Infect Dis 2000; 182: 526-33.
36. Dentener MA, Francot GJ, Hiemstra PS, et al. Bactericidal/ permeability-increasing protein release in whole blood ex vivo: strong induction by lipopolysaccharide and tumor necrosis factor-alpha. J Infect Dis 1997; 175: 108-17.
37. Dentener MA, Francot GJ, Smit FT, et al. Presence of bactericidal/permeability-increasing protein in disease: detection by ELISA. J Infect Dis 1995; 171: 739-43.
38. Gazzano-Santoro H, Meszaros K, Birr C, et al. Competition between rBPI23, a recombinant fragment of bactericidal/ permeability-increasing protein, and lipopolysaccharide (LPS)-binding protein for binding to LPS and gramnegative bacteria. Infect Immun 1994; 62: 1185-91.
39. Meszaros K, Parent JB, Gazzano-Santoro H, et al. A recombinant amino terminal fragment of bactericidal/ permeability-increasing protein inhibits the induction of leukocyte responses by L.P.S. J Leukoc Biol 1993; 54: 558-63.
40. Jin H, Yang R, Marsters S, et al. Protection against endotoxic shock by bactericidal/permeability-increasing protein in rats. J Clin Invest 1995; 95: 1947-52.